Abstract
Yaws is a skin debilitating disease caused by Treponema pallidum subspecies pertenue with most cases reported in children. World Health Organization (WHO) aims at total eradication of this disease through mass treatment of suspected cases followed by an intensive follow-up program. However, effective diagnosis is pivotal in the successful implementation of this control program. Recombinase polymerase amplification (RPA), an isothermal nucleic acid amplification technique offers a wider range of differentiation of pathogens including those isolated from chronic skin ulcers with similar characteristics such as Haemophilus ducreyi (H. ducreyi). We have developed a RPA assay for the simultaneous detection of Treponema pallidum (T. pallidum) and H. ducreyi (TPHD-RPA). The assay demonstrated no cross-reaction with other pathogens and enable detection of T. pallidum and H. ducreyi within 15 min at 42 °C. The RPA assay was validated with 49 clinical samples from individuals confirmed to have yaws by serological tests. Comparing the developed assay with commercial multiplex real-time PCR, the assay demonstrated 94% and 95% sensitivity for T. pallidum and H. ducreyi, respectively and 100% specificity. This simple novel TPHD-RPA assay enables the rapid detection of both T. pallidum and H. ducreyi in yaws-like lesions. This test could support the yaws eradication efforts by ensuring reliable diagnosis, to enable monitoring of program success and planning of follow-up interventions at the community level.
Highlights
Yaws, most common of the three endemic non-venereal treponemal infections is caused by Treponema pallidum sp. pertenue [1,2]
We have developed a Recombinase polymerase amplification (RPA) assay for the simultaneous detection of T. pallidum and H. ducreyi (TPHD-RPA) in Dual Path Platform (DPP) confirmed yaws patients
The limit of detection of the singleplex RPA assay at 95% probability was 11 and 6 copies of DNA molecular standard for T. pallidum and H. ducreyi respectively (Figure 2)
Summary
Most common of the three endemic non-venereal treponemal infections is caused by Treponema pallidum sp. pertenue [1,2]. The WHO aimed to achieve total eradication of yaws by 2020 through a comprehensive large-scale treatment strategy, called the Morges strategy [5] This strategy consists of an initial mass drug therapy with oral intake of azithromycin in endemic communities followed by an active surveillance every 6 months to actively detect and treat remaining cases and their contacts. Pilot implementation of this strategy in endemic countries such as Ghana, Congo, Papua New Guinea, Vanuatu, and the Solomon Islands have shown promising results, with the need for scale-up [6]. In patients with yaws-like lesions, differential diagnosis other than those cause by T. pallidum pertenue is important for accurate reporting and management of cases
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
